Cutting edge issues in the Churg-Strauss syndrome (Q37850388)

24 August 2017

1 reference

title

Cutting edge issues in the Churg-Strauss syndrome (English)

1 reference

24 August 2017

Wojciech Szczeklik

1

0 references

Jacek Musiał

series ordinal

4

object named as

Jacek Musiał

1 reference

24 August 2017

3

Dariusz Adamek

1 reference

24 August 2017

2

Bogdan Jakieła

1 reference

24 August 2017

1 February 2013

1 reference

Clinical Reviews in Allergy & Immunology

24 August 2017

1 reference

24 August 2017

44

1 reference

24 August 2017

1

1 reference

24 August 2017

39-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-011-8266-y

24 August 2017

0 references

cites work

Churg-Strauss syndrome: evidence for disease subtypes?

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

What is known about the epidemiology of the vasculitides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Churg-Strauss syndrome in a district hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Recent advances in the diagnosis of Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Involvement of soluble CD95 in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Clinicopathological features of Churg-Strauss syndrome-associated neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Clonal CD8+ TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

A retrospective study of bronchial hyperresponsiveness in patients with asthma before the onset of Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Ear, nose and throat manifestations of Churg-Strauss syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Autoimmune vasculitis preceding aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Churg-Strauss syndrome: high resolution CT and pathologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Lung involvement in Churg–Strauss syndrome as related to the activity of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Cardiac involvement in systemic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Coronary involvement in the Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Cardiac involvement in small and medium-sized vessel vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Cardiac involvement in Churg-Strauss syndrome shown by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

21 January 2018

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

21 January 2018

Churg-Strauss syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

The Churg Strauss syndrome (allergic granulomatous angiitis): review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Recent developments in the classification and assessment of vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

ANCA-associated vasculitides--advances in pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8266-Y

Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients

21 January 2018

1 reference

12 December 2020

Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

1 reference

12 December 2020

CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome

1 reference

12 December 2020

Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis

1 reference

12 December 2020

Damage occurs early in systemic vasculitis and is an index of outcome

1 reference

12 December 2020

Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production

1 reference

12 December 2020

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients

1 reference

12 December 2020

Interleukins in Churg-Strauss syndrome

1 reference

12 December 2020

Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome

1 reference

12 December 2020

Churg-Strauss syndrome

1 reference

12 December 2020

Heart involvement detected by magnetic resonance in a patient with Churg-Strauss syndrome, mimicking severe asthma exacerbation

1 reference

12 December 2020

HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome

1 reference

12 December 2020

Treatment of Churg-Strauss syndrome without poor-prognosis factors: A multicenter, prospective, randomized, open-label study of seventy-two patients

1 reference

12 December 2020

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

1 reference

12 December 2020

Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement

1 reference

12 December 2020

Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma

1 reference

12 December 2020

Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis

1 reference

12 December 2020

Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome

1 reference

12 December 2020

Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis

1 reference

12 December 2020

Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study

1 reference

12 December 2020

Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides.

1 reference

12 December 2020

Serum interleukin-5 levels in a case with allergic granulomatous angiitis

1 reference

12 December 2020

Evidence for pathogenic involvementof eosinophils and neutrophilsin Churg-Strauss syndrome

1 reference

12 December 2020

Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up

1 reference

12 December 2020

The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome

1 reference

12 December 2020

Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases

1 reference

12 December 2020

The Course of Asthma in Churg–Strauss Syndrome

1 reference

12 December 2020

Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues

1 reference

12 December 2020

Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome

1 reference

12 December 2020

The common allergens in the Churg-Strauss syndrome

1 reference

12 December 2020

Allergic granulomatosis, allergic angiitis, and periarteritis nodosa

1 reference

12 December 2020

Multimodality Assessment of Cardiac Involvement in Churg-Strauss Syndrome Patients in Clinical Remission

1 reference

12 December 2020

Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome

1 reference

12 December 2020

Spontaneous coronary arterial dissection and isolated eosinophilic coronary arteritis: sudden cardiac death in a patient with a limited variant of Churg-Strauss syndrome

1 reference

12 December 2020

Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients

1 reference

12 December 2020

Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)

1 reference

12 December 2020

Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation

1 reference

12 December 2020

A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome.

1 reference

12 December 2020

[Churg-Strauss syndrome]

1 reference

12 December 2020

Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome

1 reference

12 December 2020

Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage

1 reference

12 December 2020

Churg-Strauss syndrome

1 reference

12 December 2020

The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

1 reference

12 December 2020

Sputum eosinophilia in Churg-Strauss syndrome

1 reference

12 December 2020

Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective

1 reference

12 December 2020

Autoimmune vasculitis and aortic stenosis in aspirin-induced asthma (AIA)

1 reference

12 December 2020

Development of Churg-Strauss syndrome with severe multiple mononeuropathy after leukotriene receptor antagonist treatment in one of the monozygotic twins with asthma: case report

1 reference

12 December 2020

Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome

1 reference

12 December 2020

The analysis of mRNA expression of cytokines from skin lesions in Churg-Strauss syndrome

1 reference

12 December 2020

Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA

1 reference

12 December 2020

Cardiac involvement in Churg-Strauss syndrome

1 reference

12 December 2020

Cardiac involvement in the Churg-Strauss syndrome

1 reference

12 December 2020

Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides

1 reference

12 December 2020

Granulomatous arteritis in cutaneous lesions of Churg-Strauss syndrome

1 reference

12 December 2020

Associations of Churg-Strauss syndrome with the HLA–DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody–associated vasculitides: Comment on the article by Vaglio et al

1 reference

12 December 2020

Impaired cardiovascular autonomic nervous system function in patients with Churg–Strauss syndrome

1 reference

12 December 2020

Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients

1 reference

12 December 2020

Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity

1 reference

12 December 2020

10.1007/S12016-011-8266-Y

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21380944